Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A3CW
|
|||
Former ID |
DIB002352
|
|||
Drug Name |
Oleylphosphocholine
|
|||
Synonyms |
Oleylphosphocholine (leishmaniasis); Oleylphosphocholine (leishmaniasis), Max Planck Institute; Oleylphosphocholine (leishmaniasis), Dafra Pharma R&D
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Leishmania infection [ICD-11: 1F54.0; ICD-10: B55.0] | Investigative | [1] | |
Company |
Max-Planck-Gesellschaft zur Forderung der Wissenschaften eV
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H48NO4P
|
|||
Canonical SMILES |
CCCCCCCCC=CCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C
|
|||
InChI |
1S/C23H48NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-27-29(25,26)28-23-21-24(2,3)4/h12-13H,5-11,14-23H2,1-4H3/b13-12-
|
|||
InChIKey |
SLVOKEOPLJCHCQ-SEYXRHQNSA-N
|
|||
CAS Number |
CAS 76622-80-5
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.